Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
July 31, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
July 17, 2023 11:45 ET
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 17 July 2023 – 17:45 CEST – Mithra...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855)
July 04, 2023 11:45 ET
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 4 July 2023 – [17:45 CEST] – Mithra...
Mithra Announces Information on the Total Number of Voting Rights (Denominator)
June 26, 2023 11:45 ET
|
Mithra Pharmaceuticals
Mithra Announces Information on the Total Number of Voting Rights (Denominator) Liege, Belgium, 26 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
June 21, 2023 14:38 ET
|
Mithra Pharmaceuticals
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility Liege, Belgium, 21 June 2023 – 17:50 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the...
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program
June 15, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows synergy with PD1 cancer immune checkpoint...
Mithra - Publication of a transparency notification received from Scorpiaux BV
June 05, 2023 11:45 ET
|
Mithra Pharmaceuticals
Publication of a transparency notification received from Scorpiaux BV Liege, Belgium, 05 June 2023 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...
Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors
May 25, 2023 12:39 ET
|
Mithra Pharmaceuticals
Mithra’s General Meeting Of Shareholders Approves the Renewal of its Board of Directors Liege, Belgium, 25 MAY 2023 – 5:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to...
Mithra - Letter to Shareholders and Corporate Update
May 25, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...
Mithra - Letter to Shareholders and Corporate Update
May 25, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...